Sustained

Regeneron : EYLEA HD Shows Sustained Vision Gains In Wet AMD Patients At 3 Years

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) results for EYLEA HD (aflibercept) Injection 8 mg in patients…

4 days ago

Regeneron : EYLEA HD Shows Sustained Vision Gains In Wet AMD Patients At 3 Years

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) results for EYLEA HD (aflibercept) Injection 8 mg in patients…

4 days ago